Open access
Open access
Powered by Google Translator Translator

Global & Public Health (all articles)

WHO approves first ever malaria vaccine for children at risk.

7 Oct, 2021 | 10:40h | UTC

WHO recommends groundbreaking malaria vaccine for children at risk – World Health Organization

Commentaries:

WHO Approves First Ever Malaria Vaccine – Health Policy Watch

A historic day for malaria – reaction to WHO decision on the RTS,S vaccine – London School of Hygiene & Tropical Medicine

In major decision, WHO recommends broad rollout of world’s first malaria vaccine – STAT

Why the WHO approval of the first malaria vaccine is a big deal – Vox

WHO greenlights the world’s first malaria vaccine — but it’s not a perfect shot – NPR

The World Health Organization Just Endorsed The World’s First Malaria Vaccine – TIME

WHO Backs Widespread Use Of First Malaria Vaccine – Forbes

World’s 1st malaria vaccine recommended by WHO – LiveScience

 

Commentaries on Twitter

(thread – click for more)

 


Choosing Wisely: Seven things physicians and residents/patients should question in long term care.

7 Oct, 2021 | 10:31h | UTC

Seven Things Physicians and Residents/Patients Should Question – Canadian Society for Long Term Care Medicine

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 


Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.

7 Oct, 2021 | 10:45h | UTC

Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups – Reuters

 


The Lancet Commission: transforming access to diagnostics.

7 Oct, 2021 | 10:33h | UTC

News release: The Lancet: Half of the global population lack access to basic diagnostics for many common diseases

Video: Transforming access to diagnostics | The Lancet Commission on diagnostics

Homepage: The Lancet Commission on diagnostics: transforming access to diagnostics

The Lancet Commission on diagnostics: transforming access to diagnostics (free registration required)

Transforming access to diagnostics: how to turn good intentions into action? (free registration required)

Can COVID-19 help accelerate and transform the diagnostics agenda?

Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys

Commentary: A Grim Diagnosis – Half The World’s Population Has Limited Access To Diagnostics – Forbes

Related:

WHO Updates Global Guidance on Medicines and Diagnostic Tests

The WHO Essential Diagnostic List: A Tool for the Future

Perspective: Health Care is an Essential Human Right – And So Is a Proper Diagnosis

Report: First-ever WHO List of Essential Diagnostic Tests

 

Commentary on Twitter

https://twitter.com/DiagnosticsCom/status/1445879305536483332

 


Cohort Study: Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumor types in 61 countries.

6 Oct, 2021 | 10:09h | UTC

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study – The Lancet Oncology

 

Commentary on Twitter (thread – click for more)

 


Opinion | Why Are Americans Still—Still!—Wearing Cloth Masks?

6 Oct, 2021 | 10:04h | UTC

Why Are Americans Still—Still!—Wearing Cloth Masks? – The Atlantic

Related:

Evidence shows that, yes, masks prevent COVID-19 – and surgical masks are the way to go.

Face masks for COVID pass their largest test yet – “A rigorous study finds that surgical masks are highly protective, but cloth masks fall short”.

[Preprint] Largest study of masks yet details their importance in fighting Covid-19.

 

Commentary on Twitter

 


EMA recommendations on extra doses and boosters of BioNTech/Pfizer and Moderna mRNA vaccines.

6 Oct, 2021 | 10:15h | UTC

Comirnaty and Spikevax: EMA recommendations on extra doses and boosters – European Medicines Agency

Related: The difference between COVID-19 ‘third doses’ and ‘boosters’ – Emory News Center

 

Commentary on Twitter

 


What we know — and don’t know — about Merck’s new Covid-19 pill.

6 Oct, 2021 | 10:07h | UTC

What we know — and don’t know — about Merck’s new Covid-19 pill – STAT

Related:

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

 


Supplement: Triumphs of Vaccination.

6 Oct, 2021 | 08:55h | UTC

Homepage: Triumphs of Vaccination – The Journal of Infectious Diseases

Triumphs of Immunization

Pertussis (Whooping Cough)

Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease

The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease

Hepatitis B Vaccines

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe

Rubella Eradication: Not Yet Accomplished, but Entirely Feasible

Human Papillomavirus Vaccines

Smallpox

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster

Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication

Influenza Vaccines: Successes and Continuing Challenges

Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination

Herpes Zoster Vaccines

Overview of the United States’ Immunization Program

The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade

 


Is salt good for you after all? The evidence says no.

6 Oct, 2021 | 08:52h | UTC

Is salt good for you after all? The evidence says no – The Conversation

Related:

#ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

Systematic Review: Altered dietary salt intake for people with chronic kidney disease.

New WHO benchmarks help countries reduce salt intake and save lives.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

 


Cohort study: Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older is rare, and most cases are not severe.

5 Oct, 2021 | 10:07h | UTC

Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older – JAMA Internal Medicine

Editorial: COVID-19 Messenger RNA Vaccination and Myocarditis—A Rare and Mostly Mild Adverse Effect

 

Commentary on Twitter

 


Cohort study: Pfizer vaccine effectiveness against any infections declined from 88% during the first month after full vaccination to 47% after 5 months. Vaccine effectiveness against hospital admissions remained high; 87% within 1 month, and 88% at 5 months after full vaccination, with no significant waning.

5 Oct, 2021 | 10:09h | UTC

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study – The Lancet

Commentary: Expert reaction to study on Pfizer-BioNTech vaccine effectiveness up to 6 months – Science Media Centre

 

Commentary on Twitter

 


New Zealand acknowledges it can no longer completely get rid of the coronavirus.

5 Oct, 2021 | 10:02h | UTC

New Zealand acknowledges it can no longer completely get rid of the coronavirus – NPR

See also:

Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore – The Lancet

New Zealand admits it can no longer get rid of coronavirus – Associated Press

Battling Delta, New Zealand Abandons Its Zero-Covid Ambitions – The New York Times

 


Video | A Pill For COVID? A Doctor Explains Molnupiravir.

5 Oct, 2021 | 09:57h | UTC

A Pill For COVID? | A Doctor Explains Molnupiravir – ZDoggMD

 


Merck’s Covid-19 pill is great news but may not be a game-changer.

5 Oct, 2021 | 09:59h | UTC

Merck’s Covid-19 pill is great news but may not be a game-changer – CNN

 


AAN Position Statement: Ethical perspectives on costly drugs and health care.

5 Oct, 2021 | 08:57h | UTC

Ethical Perspectives on Costly Drugs and Health Care: AAN Position Statement – Neurology

News release: AAN Issues Ethics Position Statement on Costly Drugs and Health Care – American Academy of Neurology

 


[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

3 Oct, 2021 | 23:02h | UTC

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study

Commentaries:

Expert reaction to interim analysis of oral antiviral molnupiravir – Science Media Centre

Merck’s antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment – STAT

Covid antiviral pill can halve risk of hospitalization – BBC

Why Merck’s Covid-19 pill molnupiravir could be so important – Vox

‘Unquestionably a game changer!’ Antiviral pill cuts COVID-19 hospitalization risk – Researchers excited about Merck drug, but caution data are preliminary and price is high – Science

 

Commentaries on Twitter

(thread – click for more)

 


[Preprint] Assessing the Burden of COVID-19 in Developing Countries: Systematic Review, Meta-Analysis, and Public Policy Implications.

3 Oct, 2021 | 22:56h | UTC

Assessing the Burden of COVID-19 in Developing Countries: Systematic Review, Meta-Analysis, and Public Policy Implications – medRxiv

 

Commentary on Twitter

https://twitter.com/GidMK/status/1444125087553114113

 


Will the pandemic fade into an ordinary disease like the flu? The world is watching Denmark for clues.

3 Oct, 2021 | 22:58h | UTC

Will the pandemic fade into an ordinary disease like the flu? The world is watching Denmark for clues – Science

 


New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks.

3 Oct, 2021 | 22:52h | UTC

News release: New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks – The Royal Society of Medicine

Original report: Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis

Related: Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors.

 


Editorial | Clinical ethics: consent for vaccination in children.

3 Oct, 2021 | 22:53h | UTC

Clinical ethics: consent for vaccination in children – Archives of Disease in Childhood

 


Editorial | Covid-19 vaccination: evidence of waning immunity is overstated.

3 Oct, 2021 | 22:49h | UTC

Covid-19 vaccination: evidence of waning immunity is overstated – The BMJ

Related:

COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”.

COVID vaccine effects wane over time but still prevent death and severe illness.

Perspective | What we actually know about waning immunity.

Another study shows Pfizer mRNA vaccine immunity is reduced over time.

[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.

Studies: COVID vaccine protection waning against infection but not hospitalization.

Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.

 


WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists.

3 Oct, 2021 | 22:46h | UTC

News Release: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists – World Health Organization

Report: WHO model list of essential medicines – 22nd list, 2021 – World Health Organization

Commentary: For the first time, WHO committee recommends action on high-priced essential medicines – STAT

 

Commentary on Twitter (thread – click for more)

 


Physician Well-being 2.0: Where Are We and Where Are We Going?

3 Oct, 2021 | 22:36h | UTC

Physician Well-being 2.0: Where Are We and Where Are We Going? – Mayo Clinic Proceedings

Related:

Consensus Study – Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being – National Academies of Medicine

[Abstract Only] Assessment of Risk Factors for Suicide Among US Health Care Professionals

Beyond Burnout: Docs Decry ‘Moral Injury’ From Financial Pressures of Health Care

Perspective: Hospital Administration Response to Physician Stress and Burnout

Opinion: It’s Time to Talk About Physician Burnout and Moral Injury

Systematic Review: Effect of Organization-Directed Workplace Interventions on Physician Burnout

Perspective: The 3 Causes Of Physician Burnout (And Why There’s No Simple Solution)

Physician Burnout: A Global Crisis (several resources on the subject)

 


Efficient and targeted COVID-19 border testing via reinforcement learning.

1 Oct, 2021 | 10:33h | UTC

Efficient and targeted COVID-19 border testing via reinforcement learning – Nature

Editorial: Greece used AI to curb COVID: what other nations can learn – Nature

Commentary: An algorithm may have helped slow the spread of COVID-19 in Greece – University of Southern California

 

Commentary on Twitter

https://twitter.com/NaturePortfolio/status/1440810407334080519

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.